UPDATE: B.Riley/FBR Starts Tocagen Inc. (TOCA) at Buy, 'Breakthrough Data De-risk Phase III Brain Viral Therapy'
(Updated - May 16, 2018 8:30 AM EDT)
(updated to add analyst comments)B.Riley/FBR initiates coverage on Tocagen Inc. (NASDAQ ...
(Premium-only article. Please sign in or upgrade to SI Premium to view.)
(updated to add analyst comments)B.Riley/FBR initiates coverage on Tocagen Inc. (NASDAQ ...
(Premium-only article. Please sign in or upgrade to SI Premium to view.)